Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/8960
Full metadata record
DC FieldValueLanguage
dc.contributor.authorКаримов М.М., Зуфаров П.С., Собирова Г.Н., Каримова Д.К., Хайруллаева С.С.-
dc.date.accessioned2023-09-17T10:24:14Z-
dc.date.available2023-09-17T10:24:14Z-
dc.date.issued2023-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/8960-
dc.description.abstractIt has been shown that in patients with GERD and functional dyspepsia, the use of proton pump inhibitors leads to a decrease in heartburn and pain behind the sternum. However, symptoms such as regurgitation, belching, feeling of early satiety and heaviness after eating were stopped ineffectively. The inclusion in the treatment complex of the prokinetic domperidone at a dose of 10 mg 3 times a day contributed to a more eff ective regression of symptoms of impaired motility of the esophagus and stomachen_US
dc.language.isootheren_US
dc.publisherЭксперементальная и клиническая гастроэнтерология №211(3). 2023.С. 42-45en_US
dc.relation.ispartofseries№211(3). 2023;DOI: 10.31146/1682-8658-ecg-211-3-41-45-
dc.subjectgastroesophageal refl ux disease, functional dyspepsia, proton pump inhibitors, prokineticsen_US
dc.titleКомбинированная терапия гастроэзофагеальной рефлюксной болезни при коморбидности с функциональной диспепсиейen_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.